Peer-reviewedPublisher termsRSC Medicinal Chemistry
Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors
- 1Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University 103 Wenhua Road, Shenhe District 110016 Shenyang China
Related
- Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies
- Rhodanine and 2,4-dioxothiazolidine-based amides: synthesis and evaluation as dual-action cholinesterase inhibitors and antioxidants.
- Design, synthesis, and biological evaluation of naphthalimide derivatives as dual monoamine oxidase-B and amyloid-β aggregation inhibitors for Alzheimer's disease.
- Design, synthesis, and docking analysis of benzene sulfonamide-[1,4]benzoxazepine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors
- Androgen Synthesis Inhibitors vs Androgen Receptor Inhibitors and Survival in Metastatic Hormone-Sensitive Prostate Cancer.
BibTeX
@article{gao2026design,
title = {{Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors}},
author = {Zixuan Gao and Cancan Cui and Mingshuo Chen and Wenzhan Hao and Kejian Li and Cunzheng Fan and Zirui Luo and Xin Su and Dongmei Zhao and Maosheng Cheng},
journal = {RSC Medicinal Chemistry},
year = {2026},
month = oct,
doi = {10.1039/d6md00652c},
url = {https://doi.org/10.1039/d6md00652c},
}
RIS
TY - JOUR
TI - Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors
AU - Zixuan Gao
AU - Cancan Cui
AU - Mingshuo Chen
AU - Wenzhan Hao
AU - Kejian Li
AU - Cunzheng Fan
AU - Zirui Luo
AU - Xin Su
AU - Dongmei Zhao
AU - Maosheng Cheng
PY - 2026
DA - 2026/10/22
JO - RSC Medicinal Chemistry
DO - 10.1039/d6md00652c
UR - https://doi.org/10.1039/d6md00652c
SN - 2632-8682
ER -